Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Binmei Biotechnology is a specialized high-tech enterprise focused on the research, development, and large-scale production of natural colors and functional ingredients derived from algae. The company is a global leader in the extraction of phycocyanin, a natural blue pigment from spirulina, utilizing proprietary low-temperature extraction technologies that preserve the protein's bioactivity. Their product portfolio serves the food, beverage, nutraceutical, and cosmetic sectors, providing clean-label alternatives to synthetic dyes. Binmei operates advanced manufacturing facilities that adhere to international quality standards, including GMP, ISO22000, and HACCP. With a strong emphasis on R&D, the company continues to explore the therapeutic potential of algal proteins in areas such as antioxidant and anti-inflammatory health. Headquartered in Taizhou, China, Binmei exports its products to over 40 countries worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Binmei Biotechnology.